Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery - PubMed (original) (raw)
Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery
S Wei et al. Eur J Pharmacol. 1997.
Abstract
Hydralazine relaxed porcine coronary artery strips in a concentration-dependent manner by distinct endothelium-dependent and endothelium-independent actions. With lower doses (< or = 10(-6) M), the hydralazine-induced relaxation appears to be completely endothelium-dependent and we designed the present study to elucidate the mechanisms of this endothelium-dependent relaxation. Hydralazine (10(-6) M)-induced endothelium-dependent relaxation was not affected by the presence of 10(-5) M indomethacin, 10(-3) M L-NG-nitro-arginine (L-NOARG) or 10(-5) M haemoglobin, and was accompanied by accumulation of cGMP but not of cAMP in artery strips. There was a close time-dependent parallel relationship between endothelium-dependent relaxation and accumulation of cGMP induced by hydralazine (10(-6) M). The endothelium-dependent relaxation and accumulation of cGMP induced by hydralazine showed much slower kinetics than those induced by ionomycin (10(-7) M). Pretreatment of the strips with actinomycin D (10 micrograms/ml) significantly inhibited not the endothelium-dependent relaxation and accumulation of cGMP induced by ionomycin (10(-7) M) but those induced by hydralazine (10(-6) M). These results suggest that hydralazine induces endothelium-dependent vasorelaxation via the slow accumulation of cGMP in the strips. This does not occur through the release of nitric oxide or prostaglandin I2 but through immediate transcription and probably expression of a molecule in the endothelium.
Similar articles
- The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery.
Kühberger E, Groschner K, Kukovetz WR, Brunner F. Kühberger E, et al. Br J Pharmacol. 1994 Dec;113(4):1289-94. doi: 10.1111/j.1476-5381.1994.tb17138.x. Br J Pharmacol. 1994. PMID: 7889285 Free PMC article. - Characterization of endothelium-dependent relaxations resistant to nitro-L-arginine in the porcine coronary artery.
Nagao T, Vanhoutte PM. Nagao T, et al. Br J Pharmacol. 1992 Dec;107(4):1102-7. doi: 10.1111/j.1476-5381.1992.tb13414.x. Br J Pharmacol. 1992. PMID: 1467832 Free PMC article. - Relaxation induced by acetylcholine involves endothelium-derived hyperpolarizing factor in 2-kidney 1-clip hypertensive rat carotid arteries.
Sendão Oliveira AP, Bendhack LM. Sendão Oliveira AP, et al. Pharmacology. 2004 Dec;72(4):231-9. doi: 10.1159/000080378. Pharmacology. 2004. PMID: 15539883 - Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
Rapoport RM, Murad F. Rapoport RM, et al. J Cyclic Nucleotide Protein Phosphor Res. 1983;9(4-5):281-96. J Cyclic Nucleotide Protein Phosphor Res. 1983. PMID: 6147363 Review. - Direct vasodilators with unknown modes of action: the nitro-compounds and hydralazine.
Kreye VA. Kreye VA. J Cardiovasc Pharmacol. 1984;6 Suppl 4:S646-55. doi: 10.1097/00005344-198406004-00011. J Cardiovasc Pharmacol. 1984. PMID: 6083407 Review.
Cited by
- Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.
Kalkhoran SB, Kriston-Vizi J, Hernandez-Resendiz S, Crespo-Avilan GE, Rosdah AA, Lees JG, Costa JRSD, Ling NXY, Holien JK, Samangouei P, Chinda K, Yap EP, Riquelme JA, Ketteler R, Yellon DM, Lim SY, Hausenloy DJ. Kalkhoran SB, et al. Cardiovasc Res. 2022 Jan 7;118(1):282-294. doi: 10.1093/cvr/cvaa343. Cardiovasc Res. 2022. PMID: 33386841 Free PMC article. - Control of hypertension in the critically ill: a pathophysiological approach.
Salgado DR, Silva E, Vincent JL. Salgado DR, et al. Ann Intensive Care. 2013 Jun 27;3(1):17. doi: 10.1186/2110-5820-3-17. Ann Intensive Care. 2013. PMID: 23806076 Free PMC article. - Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Benter IF, Yousif MH, Al-Saleh FM, Raghupathy R, Chappell MC, Diz DI. Benter IF, et al. J Cardiovasc Pharmacol. 2011 May;57(5):559-67. doi: 10.1097/FJC.0b013e31821324b6. J Cardiovasc Pharmacol. 2011. PMID: 21326110 Free PMC article. - Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery.
Ellershaw DC, Gurney AM. Ellershaw DC, et al. Br J Pharmacol. 2001 Oct;134(3):621-31. doi: 10.1038/sj.bjp.0704302. Br J Pharmacol. 2001. PMID: 11588117 Free PMC article. - A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo.
Andersson K, Gaudiot N, Ribiere C, Elizalde M, Giudicelli Y, Arner P. Andersson K, et al. Br J Pharmacol. 1999 Apr;126(7):1639-45. doi: 10.1038/sj.bjp.0702430. Br J Pharmacol. 1999. PMID: 10323597 Free PMC article.